ID30046A - Kemoterapi kanker dengan asetildinalina digabung dengan gemsitabina, kapestabina atau kisplatin - Google Patents

Kemoterapi kanker dengan asetildinalina digabung dengan gemsitabina, kapestabina atau kisplatin

Info

Publication number: ID30046A
Authority: ID; Indonesia
Prior art keywords: gemsitabina; capestabine; cancererapy; acethylinineine; cisplatin
Prior art date: 1998-09-25

Application number

IDW20010901A

Other languages

English (en)

Indonesian (id)

Inventor

William R Grove

Wayne D Klohs

Ronald Lynn Merriman

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-25

Filing date

1999-07-08

Publication date

2001-11-01

1999-07-08 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

2001-11-01 Publication of ID30046A publication Critical patent/ID30046A/id

Links

206010028980 Neoplasm Diseases 0.000 title 1
201000011510 cancer Diseases 0.000 title 1
DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 title 1
229960004316 cisplatin Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Inorganic Chemistry (AREA)
Oncology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

IDW20010901A 1998-09-25 1999-07-08 Kemoterapi kanker dengan asetildinalina digabung dengan gemsitabina, kapestabina atau kisplatin ID30046A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US10180998P	1998-09-25	1998-09-25

Publications (1)

Publication Number	Publication Date
ID30046A true ID30046A (id)	2001-11-01

Family

ID=22286531

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW20010901A ID30046A (id)	1998-09-25	1999-07-08	Kemoterapi kanker dengan asetildinalina digabung dengan gemsitabina, kapestabina atau kisplatin

Country Status (34)

Country	Link
US (3)	US6469058B1 (de)
EP (1)	EP1115391B1 (de)
JP (1)	JP2002525320A (de)
KR (1)	KR20010075348A (de)
CN (1)	CN1319009A (de)
AP (1)	AP2001002109A0 (de)
AT (1)	ATE225655T1 (de)
AU (1)	AU762079B2 (de)
BG (1)	BG105470A (de)
BR (1)	BR9913952A (de)
CA (1)	CA2342981A1 (de)
CZ (1)	CZ2001905A3 (de)
DE (1)	DE69903458T2 (de)
DK (1)	DK1115391T3 (de)
EA (1)	EA200100369A1 (de)
EE (1)	EE200100187A (de)
ES (1)	ES2185378T3 (de)
GE (1)	GEP20043199B (de)
HK (1)	HK1040190A1 (de)
HR (1)	HRP20010225B1 (de)
HU (1)	HUP0103640A3 (de)
ID (1)	ID30046A (de)
IL (1)	IL141951A0 (de)
IS (1)	IS5888A (de)
NO (1)	NO20011493L (de)
NZ (1)	NZ510504A (de)
OA (1)	OA11659A (de)
PL (1)	PL348673A1 (de)
PT (1)	PT1115391E (de)
SK (1)	SK3602001A3 (de)
TR (1)	TR200100859T2 (de)
WO (1)	WO2000018393A1 (de)
YU (1)	YU22401A (de)
ZA (1)	ZA200102233B (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
OA11659A (en) *	1998-09-25	2004-12-08	Warner Lambert Co	Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin.
CZ20022216A3 (cs) *	2001-07-02	2003-05-14	Warner-Lambert Company	Kombinační chemoterapie
US7850990B2 (en) *	2001-10-03	2010-12-14	Celator Pharmaceuticals, Inc.	Compositions for delivery of drug combinations
CA2383259A1 (en)	2002-04-23	2003-10-23	Celator Technologies Inc.	Synergistic compositions
US20080075762A1 (en) *	2001-10-03	2008-03-27	Paul Tardi	Compositions for delivery of drug combinations
US20040132825A1 (en) *	2002-03-04	2004-07-08	Bacopoulos Nicholas G.	Methods of treating cancer with HDAC inhibitors
US7456219B2 (en)	2002-03-04	2008-11-25	Merck Hdac Research, Llc	Polymorphs of suberoylanilide hydroxamic acid
AU2003213684C1 (en) *	2002-03-04	2008-10-23	Merck Hdac Research, Llc	Methods of inducing terminal differentiation
CN100566711C (zh) *	2002-04-15	2009-12-09	斯隆-凯特林癌症研究院	治疗癌症的化合物及其用途
US8026216B2 (en)	2002-10-24	2011-09-27	Spectrum Pharmaceuticals, Inc.	Methods and compositions for contributing to the treatment of cancers
US20070032422A1 (en)	2002-10-24	2007-02-08	Spectrum Pharmaceuticals, Inc.	Methods, compositions and articles of manufacture for contributing to the treatment of cancers
GB0226434D0 (en) *	2002-11-13	2002-12-18	Astrazeneca Ab	Combination product
AU2003274576A1 (en) *	2002-11-15	2004-06-15	Warner-Lambert Company Llc	Combination chemotherapy comprising a mek inhibitor and capecitabine for treating cancer
RU2240117C1 (ru) *	2003-04-01	2004-11-20	Алтайский государственный медицинский университет	Способ лечения больных с местнораспространенными формами плоскоклеточного рака с локализацией в области слизистой оболочки полости рта и ротового отдела глотки
EP1643971A2 (de) *	2003-05-22	2006-04-12	Neopharm, Inc.	Liposomale formulierungen mit einer kombination aus zwei oder mehr wirkstoffen
PE20050206A1 (es) *	2003-05-26	2005-03-26	Schering Ag	Composicion farmaceutica que contiene un inhibidor de histona deacetilasa
CN100431606C (zh) *	2004-11-22	2008-11-12	山东蓝金生物工程有限公司	一种抗癌药物组合物
US7957507B2 (en)	2005-02-28	2011-06-07	Cadman Patrick F	Method and apparatus for modulating a radiation beam
CN100443081C (zh) *	2005-04-05	2008-12-17	吴一心	木犀草素与一种铂类化疗药物联合用于制备抗肿瘤的药物
US8232535B2 (en)	2005-05-10	2012-07-31	Tomotherapy Incorporated	System and method of treating a patient with radiation therapy
US8767917B2 (en)	2005-07-22	2014-07-01	Tomotherapy Incorpoated	System and method of delivering radiation therapy to a moving region of interest
EP1907065B1 (de)	2005-07-22	2012-11-07	TomoTherapy, Inc.	Verfahren und system zur anpassung eines strahlentherapiebehandlungsplans auf der grundlage eines biologischen modells
JP2009507524A (ja)	2005-07-22	2009-02-26	トモセラピー・インコーポレーテッド	変形マップに制約を課す方法およびそれを実装するためのシステム
US8229068B2 (en)	2005-07-22	2012-07-24	Tomotherapy Incorporated	System and method of detecting a breathing phase of a patient receiving radiation therapy
US8442287B2 (en)	2005-07-22	2013-05-14	Tomotherapy Incorporated	Method and system for evaluating quality assurance criteria in delivery of a treatment plan
EP1907064B1 (de)	2005-07-22	2011-06-08	TomoTherapy, Inc.	Verfahren zur bestimmung eines interessierenden bereiches von oberflächenstrukturen mit einem dosiervolumenhistogramm
WO2007014104A2 (en)	2005-07-22	2007-02-01	Tomotherapy Incorporated	System and method of evaluating dose delivered by a radiation therapy system
WO2007014108A2 (en) *	2005-07-22	2007-02-01	Tomotherapy Incorporated	Method and system for evaluating quality assurance criteria in delivery of a treament plan
CN101268474A (zh)	2005-07-22	2008-09-17	断层放疗公司	用于估算实施剂量的方法和系统
EP1970097A3 (de)	2005-07-22	2009-10-21	TomoTherapy, Inc.	Verfahren und System zur Vorhersage der Dosierabgabe
WO2007014093A2 (en)	2005-07-22	2007-02-01	Tomotherapy Incorporated	Method and system for processing data relating to a radiation therapy treatment plan
EP1907057B1 (de)	2005-07-23	2017-01-25	TomoTherapy, Inc.	Vorrichtung zur strahlungstherapiebildgebung und abgabe mttels koordinierter bewegung von gantry und liege
CN101534852B (zh) *	2006-08-31	2013-02-13	光谱医药公司	通过施用内皮素激动剂使得肿瘤细胞对放疗敏化
US8436044B2 (en) *	2008-01-28	2013-05-07	Nanocarrier Co., Ltd.	Pharmaceutical composition or combination drug
FR2937867B1 (fr) *	2008-11-03	2011-03-04	Biorebus	Association pharmaceutique contenant l acide lipoique et l acide hydroxycitrique a titre de principes actifs.
EP2417146B1 (de)	2009-04-06	2016-07-13	Otsuka Pharmaceutical Co., Ltd.	Derives de la (2'-deoxy-ribofuranosyl)-1,3,4,7-tetrahydro-(1,3)diazepin-2-one pour le traitment du cancer
WO2012003413A1 (en) *	2010-06-30	2012-01-05	The Broad Institute, Inc.	Novel solid forms of tacedinaline
US8691875B2 (en)	2011-07-01	2014-04-08	Broad Institute, Inc.	Solid forms of tacedinaline
US9308235B2 (en)	2012-05-09	2016-04-12	Spectrum Pharmaceuticals, Inc.	Treatment of primary and metastatic carcinoma
EP2711007A1 (de)	2012-09-19	2014-03-26	Institut Univ. de Ciència i Tecnologia, S.A.	4-Aminopyrazolo[3,4-d]pyrimidine zur Verwendung bei der Behandlung oder Vorbeugung von primärem und metastatischem Brust- und Prostatakrebs
EP2711009A1 (de)	2012-09-19	2014-03-26	Institut Univ. de Ciència i Tecnologia, S.A.	Verbindungen zur Verwendung bei der Behandlung oder Vorbeugung von primärem und metastatischem Brust- und Prostatakrebs
EP2711008A1 (de)	2012-09-19	2014-03-26	Institut Univ. de Ciència i Tecnologia, S.A.	N6,N6-dimethyladenosine zur Verwendung bei der Behandlung oder Vorbeugung von primärem und metastatischem Brustkrebs
JP6412020B2 (ja)	2013-02-26	2018-10-24	アキュレイインコーポレイテッド	電磁作動式のマルチリーフコリメーター
US10189797B2 (en) *	2015-12-30	2019-01-29	Duke University	Chemical modulators of immune checkpoints and therapeutic use
WO2020028392A1 (en)	2018-07-30	2020-02-06	Duke University	Niclosamide analogues and therapeutic use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5562925A (en) *	1970-04-20	1996-10-08	Research Corporation Tech. Inc.	Anti-tumor method
NZ219974A (en) *	1986-04-22	1989-08-29	Goedecke Ag	N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases
AU671491B2 (en) *	1992-12-18	1996-08-29	F. Hoffmann-La Roche Ag	N-oxycarbonyl substituted 5'-deoxy-5-fluorcytidines
WO1998047500A1 (en)	1997-04-24	1998-10-29	Warner-Lambert Company	Use of acetyldinaline for the manufacture of a medicament for the treatment of renal cell carcinoma
US5972986A (en) *	1997-10-14	1999-10-26	G.D. Searle & Co.	Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
OA11659A (en) *	1998-09-25	2004-12-08	Warner Lambert Co	Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin.

1999
- 1999-07-08 OA OA1200100078A patent/OA11659A/en unknown
- 1999-07-08 CN CN99811320A patent/CN1319009A/zh active Pending
- 1999-07-08 EP EP99935442A patent/EP1115391B1/de not_active Expired - Lifetime
- 1999-07-08 HK HK02101589.3A patent/HK1040190A1/zh unknown
- 1999-07-08 DK DK99935442T patent/DK1115391T3/da active
- 1999-07-08 PL PL99348673A patent/PL348673A1/xx not_active Application Discontinuation
- 1999-07-08 HU HU0103640A patent/HUP0103640A3/hu unknown
- 1999-07-08 EA EA200100369A patent/EA200100369A1/ru unknown
- 1999-07-08 AU AU50921/99A patent/AU762079B2/en not_active Ceased
- 1999-07-08 AP APAP/P/2001/002109A patent/AP2001002109A0/en unknown
- 1999-07-08 DE DE69903458T patent/DE69903458T2/de not_active Expired - Fee Related
- 1999-07-08 ID IDW20010901A patent/ID30046A/id unknown
- 1999-07-08 BR BR9913952-9A patent/BR9913952A/pt not_active IP Right Cessation
- 1999-07-08 AT AT99935442T patent/ATE225655T1/de not_active IP Right Cessation
- 1999-07-08 HR HR20010225A patent/HRP20010225B1/xx not_active Application Discontinuation
- 1999-07-08 EE EEP200100187A patent/EE200100187A/xx unknown
- 1999-07-08 YU YU22401A patent/YU22401A/sh unknown
- 1999-07-08 NZ NZ510504A patent/NZ510504A/en unknown
- 1999-07-08 TR TR2001/00859T patent/TR200100859T2/xx unknown
- 1999-07-08 CA CA002342981A patent/CA2342981A1/en not_active Abandoned
- 1999-07-08 US US09/744,130 patent/US6469058B1/en not_active Expired - Fee Related
- 1999-07-08 JP JP2000571912A patent/JP2002525320A/ja active Pending
- 1999-07-08 IL IL14195199A patent/IL141951A0/xx unknown
- 1999-07-08 CZ CZ2001905A patent/CZ2001905A3/cs unknown
- 1999-07-08 WO PCT/US1999/015386 patent/WO2000018393A1/en not_active Ceased
- 1999-07-08 KR KR1020017003794A patent/KR20010075348A/ko not_active Withdrawn
- 1999-07-08 PT PT99935442T patent/PT1115391E/pt unknown
- 1999-07-08 ES ES99935442T patent/ES2185378T3/es not_active Expired - Lifetime
- 1999-07-08 GE GEAP19995872A patent/GEP20043199B/en unknown
- 1999-07-08 SK SK360-2001A patent/SK3602001A3/sk unknown
2001
- 2001-03-14 IS IS5888A patent/IS5888A/is unknown
- 2001-03-16 ZA ZA200102233A patent/ZA200102233B/en unknown
- 2001-03-23 NO NO20011493A patent/NO20011493L/no not_active Application Discontinuation
- 2001-04-25 BG BG105470A patent/BG105470A/xx unknown
2002
- 2002-10-08 US US10/184,309 patent/US20030170300A1/en not_active Abandoned
- 2002-10-09 US US10/185,221 patent/US20030086965A1/en not_active Abandoned

Also Published As

Publication number	Publication date
BR9913952A (pt)	2001-06-12
US20030086965A1 (en)	2003-05-08
HK1040190A1 (zh)	2002-05-31
HUP0103640A2 (en)	2002-06-29
GEP20043199B (en)	2004-03-25
BG105470A (en)	2001-12-29
EP1115391A1 (de)	2001-07-18
SK3602001A3 (en)	2002-07-02
JP2002525320A (ja)	2002-08-13
PL348673A1 (en)	2002-06-03
AU5092199A (en)	2000-04-17
IS5888A (is)	2001-03-14
DK1115391T3 (da)	2003-02-10
WO2000018393A1 (en)	2000-04-06
CN1319009A (zh)	2001-10-24
YU22401A (sh)	2004-03-12
NZ510504A (en)	2003-09-26
HRP20010225A2 (en)	2002-04-30
DE69903458D1 (de)	2002-11-14
KR20010075348A (ko)	2001-08-09
EP1115391B1 (de)	2002-10-09
DE69903458T2 (de)	2003-07-10
CZ2001905A3 (cs)	2001-08-15
CA2342981A1 (en)	2000-04-06
TR200100859T2 (tr)	2001-08-21
NO20011493D0 (no)	2001-03-23
ZA200102233B (en)	2002-06-18
NO20011493L (no)	2001-05-23
ATE225655T1 (de)	2002-10-15
ES2185378T3 (es)	2003-04-16
OA11659A (en)	2004-12-08
EE200100187A (et)	2002-08-15
HRP20010225B1 (en)	2004-10-31
US20030170300A1 (en)	2003-09-11
HUP0103640A3 (en)	2003-01-28
IL141951A0 (en)	2002-03-10
AU762079B2 (en)	2003-06-19
US6469058B1 (en)	2002-10-22
AP2001002109A0 (en)	2001-03-31
PT1115391E (pt)	2003-02-28
EA200100369A1 (ru)	2001-10-22

Publication	Publication Date	Title
ID30046A (id)	2001-11-01	Kemoterapi kanker dengan asetildinalina digabung dengan gemsitabina, kapestabina atau kisplatin
LU93311I2 (fr)	2017-01-26	Mancozèbe, valifenalate
CU23049A3 (es)	2005-06-24	Dihidropirimidinas.
IT1307274B1 (it)	2001-10-30	Fibbia.
IT1312540B1 (it)	2002-04-22	Composto.
IT1307057B1 (it)	2001-10-23	Fibbia.
NO20013099L (no)	2001-08-20	Kombinasjonskjemoterapi
NL1013360A1 (nl)	1999-11-17	Bouwkundige afscherming.
ID26184A (id)	2000-12-07	Hidrogenase alfa, omega-dinitril alifatik
IT1306882B1 (it)	2001-10-11	Innesto elettromagnetico.
DE69805858D1 (de)	2002-07-11	Geschlossene wulstkonstruktion
NO995727D0 (no)	1999-11-22	Baereanordning
IT1304039B1 (it)	2001-03-02	Gommatore.
BR9908946B1 (pt)	2009-05-05	forração.
IT1308896B1 (it)	2002-01-11	Innesto elettromagnetico.
NO306323B1 (no)	1999-10-25	Kokeapparat
ES1040892Y (es)	1999-10-01	Luminaria empotrable.
ES1041377Y (es)	1999-11-16	Lampara.
ES1041087Y (es)	1999-10-16	Lampara.
ES1040945Y (es)	1999-10-01	Cocedor.
ES1042604Y (es)	2000-02-01	Conjunto de iluminacion.
ES1042117Y (es)	2000-01-01	Mesa-sombrilla.
ES1039730Y (es)	1999-06-01	Rodapie.
ES1040589Y (es)	1999-08-16	Expositor-dispensador.
ES1040633Y (es)	1999-10-01	Escalifono.